AU8203198A - Paclitaxel compositions containing hyaluronic acid of a molecular weight of lessthan 750.000 da - Google Patents

Paclitaxel compositions containing hyaluronic acid of a molecular weight of lessthan 750.000 da

Info

Publication number
AU8203198A
AU8203198A AU82031/98A AU8203198A AU8203198A AU 8203198 A AU8203198 A AU 8203198A AU 82031/98 A AU82031/98 A AU 82031/98A AU 8203198 A AU8203198 A AU 8203198A AU 8203198 A AU8203198 A AU 8203198A
Authority
AU
Australia
Prior art keywords
lessthan
molecular weight
hyaluronic acid
compositions containing
containing hyaluronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82031/98A
Inventor
Samuel S. Asculai
Adrian Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyal Pharmaceutical Corp
Original Assignee
Hyal Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyal Pharmaceutical Corp filed Critical Hyal Pharmaceutical Corp
Publication of AU8203198A publication Critical patent/AU8203198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU82031/98A 1997-07-09 1998-07-08 Paclitaxel compositions containing hyaluronic acid of a molecular weight of lessthan 750.000 da Abandoned AU8203198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2208924 1997-07-09
CA002208924A CA2208924A1 (en) 1997-07-09 1997-07-09 Sparing paclitaxel by the use of hyaluronan
PCT/CA1998/000660 WO1999002151A1 (en) 1997-07-09 1998-07-08 Paclitaxel compositions containing hyaluronic acid of a molecular weight of less than 750.000 da

Publications (1)

Publication Number Publication Date
AU8203198A true AU8203198A (en) 1999-02-08

Family

ID=4160954

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82031/98A Abandoned AU8203198A (en) 1997-07-09 1998-07-08 Paclitaxel compositions containing hyaluronic acid of a molecular weight of lessthan 750.000 da

Country Status (3)

Country Link
AU (1) AU8203198A (en)
CA (1) CA2208924A1 (en)
WO (1) WO1999002151A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140198B1 (en) * 1999-01-13 2007-10-31 Alchemia Oncology Pty Limited Use of hyaluronan for the manufacture of a medicament for the enhancement of the efficacy of cytotoxic drugs
US6593308B2 (en) * 1999-12-03 2003-07-15 The Regents Of The University Of California Targeted drug delivery with a hyaluronan ligand
WO2001047561A1 (en) 1999-12-28 2001-07-05 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
IT1318403B1 (en) 2000-03-17 2003-08-25 Cooperativa Ct Ricerche Poly T POLYSACCHARID ESTERS OF N-DERIVATIVES OF GLUTAMIC ACID.
AUPQ879500A0 (en) 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
ITPD20020271A1 (en) 2002-10-18 2004-04-19 Fidia Farmaceutici CHEMICAL-PHARMACEUTICAL COMPOUNDS CONSISTING OF TAXAN DERIVATIVES COVALENTLY LINKED TO HYALURONIC ACID OR ITS DERIVATIVES.
US7326421B2 (en) 2002-10-21 2008-02-05 Kensey Nash Corporation Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues
CA2508536A1 (en) * 2002-12-04 2004-06-17 Technologies Biolactis Inc. An exopolysaccharides delivery system for active molecules
CA2616607C (en) 2005-07-27 2015-06-02 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
MY149606A (en) 2005-09-07 2013-09-13 Alchemia Oncology Pty Ltd Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
PL2543357T3 (en) * 2011-07-07 2018-08-31 Holy Stone Healthcare Co.,Ltd. Composition for use in treating and preventing inflammation related disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8900422D0 (en) * 1989-02-08 1989-02-08 Pharmacia Ab CIRCULATED HYALURONATE GELS AND PROCEDURES FOR PREPARING THESE
CA2122519C (en) * 1994-04-29 2001-02-20 Rudolf Edgar Dr. Falk Cancer treatment and metastasis prevention
AU4406793A (en) * 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
SE9301422D0 (en) * 1993-04-28 1993-04-28 Kabi Pharmacia Ab METHOD AND MEANS FOR INHIBITING POSTERIOR CAPSULE OPACIFICATION

Also Published As

Publication number Publication date
CA2208924A1 (en) 1999-01-09
WO1999002151A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
AU5278096A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
AU6216296A (en) Pharmaceutical compositions
AU1180997A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
AU3606399A (en) Increasing the molecular weight of polyesters
AU7751794A (en) Low viscosity curable organosiloxane compositions
AU5508096A (en) 1,3-propane diol derivatives as bioactive compounds
AU5402296A (en) Pharmaceutical composition for transdermic administration
AU4966497A (en) Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
AU6805096A (en) Coating compositions with low molecular weight carbamate or urea component
AU5582096A (en) Organosiloxane compositions
AU4762797A (en) Pharmaceutical compositions
AU8055398A (en) Conditioning shampoo composition comprising high molecular weight ester oil
AU2967597A (en) Pharmaceutical compositions
AU7676096A (en) Near tricritical point compositions
AU8203198A (en) Paclitaxel compositions containing hyaluronic acid of a molecular weight of lessthan 750.000 da
AU6488998A (en) Polymer compositions
AU1120597A (en) Polymeric compositions
AU8107998A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU1422797A (en) Polyamide or polyester compositions
AU3880097A (en) Low molecular weight dendritic compounds as pharmaceutical agents
AU4163196A (en) Low molecular weight thrombopoietin
AU8147094A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
AU6346394A (en) Stabilised polymer compositions